{"data":[{"accessionNo":"0001921094-26-001138","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":36783,"aggregateMarketValue":3390075,"unitsOutstanding":48836965,"approxSaleDate":"2026-11-02","exchange":"NASDAQ","filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-001125","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Paolini John F.","relationship":"Officer","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":96000,"aggregateMarketValue":8930275,"unitsOutstanding":48836965,"approxSaleDate":"2026-10-30","exchange":"NASDAQ","filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-001126","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":47540,"aggregateMarketValue":4559561,"unitsOutstanding":48836965,"approxSaleDate":"2026-10-30","exchange":"NASDAQ","filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-001127","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Moat Ross","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":103585,"aggregateMarketValue":9753812,"unitsOutstanding":48836965,"approxSaleDate":"2026-10-30","exchange":"NASDAQ","filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-001129","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Patel Sanj K","relationship":"Officer, Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":553794,"aggregateMarketValue":51571367,"unitsOutstanding":48836965,"approxSaleDate":"2026-10-30","exchange":"NASDAQ","filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000988","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":4600,"aggregateMarketValue":369380,"unitsOutstanding":48289273,"approxSaleDate":"2026-09-03","exchange":"NASDAQ","filedAt":"2026-09-03","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000768","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Former Affiliate","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":67062,"aggregateMarketValue":5347344,"unitsOutstanding":48289273,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000767","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Cole G Bradley","relationship":"Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":3673,"aggregateMarketValue":299092,"unitsOutstanding":48289273,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000432","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Paolini John F.","relationship":"Officer","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":58424,"aggregateMarketValue":3137710,"unitsOutstanding":46303276,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000422","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Patel Sanj K","relationship":"Officer, Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":344591,"aggregateMarketValue":17780309,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-28","exchange":"NASDAQ","filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000387","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Moat Ross","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":1703,"aggregateMarketValue":79513,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-09","exchange":"NASDAQ","filedAt":"2026-04-09","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000386","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":6625,"aggregateMarketValue":309321,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-09","exchange":"NASDAQ","filedAt":"2026-04-09","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000372","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Quart Barry D","relationship":"Director","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":20000,"aggregateMarketValue":1000000,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-06","exchange":"NASDAQ","filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000371","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Patel Sanj K","relationship":"Officer, Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":219591,"aggregateMarketValue":10979550,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-06","exchange":"NASDAQ","filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000368","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Moat Ross","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":2367,"aggregateMarketValue":114989,"unitsOutstanding":45900637,"approxSaleDate":"2026-04-06","exchange":"NASDAQ","filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000294","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":36722,"aggregateMarketValue":1686179,"unitsOutstanding":45900637,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-26-000239","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Paolini John F.","relationship":"Officer","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":40000,"aggregateMarketValue":1792970,"unitsOutstanding":45900637,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001555","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Quart Barry D","relationship":"Director","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":58889,"aggregateMarketValue":2444530,"unitsOutstanding":45161019,"approxSaleDate":"2025-12-15","exchange":"NASDAQ","filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001502","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":72686,"aggregateMarketValue":3015917,"unitsOutstanding":45161019,"approxSaleDate":"2025-12-08","exchange":"NASDAQ","filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001432","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":48384,"aggregateMarketValue":2075190,"unitsOutstanding":45161019,"approxSaleDate":"2025-11-26","exchange":"NASDAQ","filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001388","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":12470,"aggregateMarketValue":514225,"unitsOutstanding":45161019,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001307","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Paolini John F.","relationship":"Officer","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":82542,"aggregateMarketValue":3065800,"unitsOutstanding":45161019,"approxSaleDate":"2025-10-31","exchange":"NASDAQ","filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001299","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":20000,"aggregateMarketValue":820000,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001298","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":20000,"aggregateMarketValue":820000,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001280","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Patel Sanj K","relationship":"Officer, Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":257969,"aggregateMarketValue":10035561,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001279","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":50490,"aggregateMarketValue":1962914,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001257","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":12368,"aggregateMarketValue":465786,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-14","exchange":"NASDAQ","filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001213","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":42000,"aggregateMarketValue":1609716,"unitsOutstanding":43472928,"approxSaleDate":"2025-09-29","exchange":"NASDAQ","filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"},{"accessionNo":"0001921094-25-001156","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":16400,"aggregateMarketValue":598016,"unitsOutstanding":43472928,"approxSaleDate":"2025-09-15","exchange":"NASDAQ","filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/knsa"}],"updatedAt":"2026-11-04T08:45:55.128Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/knsa","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}